Get the app
US › Healthcare

Smith & Nephew SNATS Inc (SNN)

US · Healthcare · Medical Devices

$29.06-0.10%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$3.10B
Revenue YoY
+9.6%
Net profit
$303.0M
Profit YoY
+41.6%
Net margin
9.8%

Key statistics

Market cap
$11.40B
P/E
18.5
Forward P/E
11.2
P/B
2.22
Book value
$2.43
EPS (TTM)
$1.47
Dividend yield
2.95%
52-week high
$36.52
52-week low
$26.07
50-day MA
$28.53
200-day MA
$31.35
Beta
0.67

Analyst view

Analysts rate Smith & Nephew SNATS Inc a hold (1 buy, 5 hold, 0 sell out of 6) with an average price target of $32.32.

Shareholding

Insiders
0.01%
Institutions
11.47%

Largest institutional holders

FundStake
River Road Asset Management, LLC0.77%
The Goldman Sachs Group Inc0.73%
Brandes Investment Partners & Co0.51%
Dimensional Fund Advisors, Inc.0.44%
LMR Partners LLP0.42%
Causeway Capital Management LLC0.37%
Wells Fargo & Co0.33%
Todd Asset Management0.30%

Recent filings & reports

DocumentDate
Notice of results (6-K) · Q4 2026
HEADLINE NUMBERS • Smith+Nephew will publish its third-quarter 2026 trading report for the period ended 26 September 2026 on Wednesday 4 November 202
2026-10-08
Redemption price of $350m 5.150% notes due 2027 (6-K) · Q4 2026
HEADLINE NUMBERS • Smith & Nephew plc will redeem the entire outstanding principal amount of its $350,000,000 5.150% Notes due 2027. • The redemptio
2026-10-01
Admission to trading (6-K) · Q3 2026
HEADLINE NUMBERS • Smith & Nephew issued and admitted 16,274 ordinary shares to trading on the London Stock Exchange Main Market. • The shares were
2026-09-18
Redemption of $350m 5.150% notes due 2027 (6-K) · Q3 2026
HEADLINE NUMBERS • Smith & Nephew plc announced the redemption of the entire outstanding $350,000,000 5.150% Notes due 2027. • The notes will be red
2026-09-18
Result of cash tender offer for 2030 bonds (6-K) · Q3 2026
HEADLINE NUMBERS • Smith+Nephew completed the results announcement for its cash tender offer for up to $250 million of its outstanding 2.032% senior
2026-09-16
Pricing of cash tender offer for 2030 bonds (6-K) · Q3 2026
HEADLINE NUMBERS • Smith+Nephew priced a cash tender offer to repurchase up to $250 million of its outstanding 2.032% Senior Notes due October 14, 20
2026-09-16
Quarterly results (6-K) · Q2 2026
HEADLINE NUMBERS • H1 2026 revenue was $3,097 million, up 4.6% reported and 2.3% underlying versus H1 2025. On an average daily sales basis, underlyi
2026-08-04
Annual report FY2025 (20-F)
HEADLINE NUMBERS • 2025 revenue was $6,164m, up 6.1% reported and 5.3% underlying, ahead of the guided target of around 5%. • Operating profit rose
2026-03-16

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.31 / share
ex-date Oct 2, 2026 · pay Nov 6, 2026
2026-10-02
Dividend$0.48 / share
ex-date Mar 27, 2026 · pay May 27, 2026
2026-03-27
Dividend$0.30 / share
ex-date Oct 3, 2025 · pay Nov 7, 2025
2025-10-03

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Smith & Nephew SNATS Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-18.